全文获取类型
收费全文 | 5298篇 |
免费 | 618篇 |
国内免费 | 168篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 218篇 |
妇产科学 | 135篇 |
基础医学 | 103篇 |
口腔科学 | 78篇 |
临床医学 | 1218篇 |
内科学 | 1203篇 |
皮肤病学 | 113篇 |
神经病学 | 306篇 |
特种医学 | 179篇 |
外科学 | 1575篇 |
综合类 | 11篇 |
预防医学 | 314篇 |
眼科学 | 325篇 |
药学 | 36篇 |
肿瘤学 | 215篇 |
出版年
2023年 | 106篇 |
2021年 | 61篇 |
2020年 | 95篇 |
2019年 | 40篇 |
2018年 | 124篇 |
2017年 | 171篇 |
2016年 | 183篇 |
2015年 | 135篇 |
2014年 | 220篇 |
2013年 | 293篇 |
2012年 | 86篇 |
2011年 | 108篇 |
2010年 | 223篇 |
2009年 | 332篇 |
2008年 | 111篇 |
2007年 | 56篇 |
2006年 | 94篇 |
2005年 | 63篇 |
2003年 | 39篇 |
2001年 | 102篇 |
2000年 | 65篇 |
1999年 | 127篇 |
1998年 | 175篇 |
1997年 | 199篇 |
1996年 | 301篇 |
1995年 | 254篇 |
1994年 | 195篇 |
1993年 | 115篇 |
1992年 | 121篇 |
1991年 | 134篇 |
1990年 | 65篇 |
1989年 | 129篇 |
1988年 | 101篇 |
1987年 | 78篇 |
1986年 | 100篇 |
1985年 | 83篇 |
1984年 | 87篇 |
1983年 | 74篇 |
1982年 | 67篇 |
1981年 | 62篇 |
1980年 | 80篇 |
1979年 | 39篇 |
1978年 | 59篇 |
1977年 | 42篇 |
1976年 | 43篇 |
1975年 | 45篇 |
1972年 | 36篇 |
1964年 | 49篇 |
1963年 | 47篇 |
1955年 | 34篇 |
排序方式: 共有6084条查询结果,搜索用时 15 毫秒
151.
152.
153.
154.
155.
David R. Matthews DPhil Carol Wysham MD Melanie Davies CBE April Slee PhD Maria Alba MD Mary Lee MPH Vlado Perkovic MBBS Kenneth W. Mahaffey MD Bruce Neal MB 《Diabetes, obesity & metabolism》2020,22(11):2199-2203
This study compared initiation of insulin and other antihyperglycaemic agents (AHAs) with canagliflozin versus placebo for participants with type 2 diabetes and a history/high risk of cardiovascular disease in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program. After 1 year, fewer participants treated with canagliflozin versus placebo initiated any AHA (7% vs. 16%), insulin (3% vs. 9%) or any non-insulin AHA (5% vs. 12%) (P < .001 for all); overall AHA initiation rates increased over time but were consistently lower with canagliflozin compared with placebo. During the study, the likelihood of initiating insulin was 2.7 times lower for participants treated with canagliflozin compared with placebo (hazard ratio, 0.37; 95% CI: 0.31, 0.43; P < .001). The time difference between 10% of patients in the canagliflozin and placebo groups being initiated on insulin from the beginning of the trial was about 2 years. Time to initiation of other AHAs, including metformin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists and sulphonylureas, was also delayed for canagliflozin versus placebo (P < .001 for each). Compared with placebo, canagliflozin delayed the need for initiation of other AHAs and delayed time to insulin therapy, an outcome that is important to many people with diabetes. 相似文献
156.
157.
158.
159.
Suzanne H. Gage BSc MSc George Davey Smith M.A. M.D. BChir MSc Stanley Zammit M.A. MB Ph.D. Matthew Hickman BSc MSc Ph.D. Marcus R. Munafò M.A. MSc Ph.D. 《Depression and anxiety》2013,30(12):1185-1193
Depression and anxiety co‐occur with substance use and abuse at a high rate. Ascertaining whether substance use plays a causal role in depression and anxiety is difficult or impossible with conventional observational epidemiology. Mendelian randomisation uses genetic variants as a proxy for environmental exposures, such as substance use, which can address problems of reverse causation and residual confounding, providing stronger evidence about causality. Genetic variants can be used instead of directly measuring exposure levels, in order to gain an unbiased estimate of the effect of various exposures on depression and anxiety. The suitability of the genetic variant as a proxy can be ascertained by confirming that there is no relationship between variant and outcome in those who do not use the substance. At present, there are suitable instruments for tobacco use, so we use that as a case study. Proof‐of‐principle Mendelian randomisation studies using these variants have found evidence for a causal effect of smoking on body mass index. Two studies have investigated tobacco and depression using this method, but neither found strong evidence that smoking causes depression or anxiety; evidence is more consistent with a self‐medication hypothesis. Mendelian randomisation represents a technique that can aid understanding of exposures that may or may not be causally related to depression and anxiety. As more suitable instruments emerge (including the use of allelic risk scores rather than individual single nucleotide polymorphisms), the effect of other substances can be investigated. Linkage disequilibrium, pleiotropy, and population stratification, which can distort Mendelian randomisation studies, are also discussed. 相似文献
160.
Yu ZhuLiangming Liu MD PhD Xiaoyong PengXiaoli Ding MB Guangming YangTao Li MD PhD 《The Journal of surgical research》2013